Theratechnologies Says Tesamorelin Review Set For May 27 - Wall Street Journal

Posted by admin! / Under Lipodystrophy

Theratechnologies Says Tesamorelin Review Set For May 27
Wall Street Journal
... an analogue of the human growth hormone releasing factor proposed for the treatment of excess abdominal fat in HIV-infected patients with lipodystrophy. ...
Theratechnologies says FDA delays fat drug review meetReuters
DJ Canada Hot Stocks To Watch: Theratechnologies, Suncor, Rona, Richmont -3-Trading Markets (press release)

all 22 news articles »

Published on Wednesday 10th of March 2010 12:03:28 PM

continue reading

Theratechnologies Announces Publication of Second Phase 3 Results in JAIDS - MarketWatch (press release)

Posted by admin! / Under Lipodystrophy

Theratechnologies Announces Publication of Second Phase 3 Results in JAIDS
MarketWatch (press release)
Several factors including a patient's antiretroviral drug regimen and the HIV virus itself are thought to contribute to HIV-associated lipodystrophy, ...

and more »

Published on Wednesday 10th of March 2010 12:03:28 PM

continue reading

Theratechnologies Inc. - Pharmaceuticals & Healthcare - Deals and Alliances ... - PR-inside.com (press release)

Posted by admin! / Under Lipodystrophy

Theratechnologies Inc. - Pharmaceuticals & Healthcare - Deals and Alliances ...
PR-inside.com (press release)
Tesamorelin is its lead product that completed its phase III clinical trails for treating HIV-associated lipodystrophy and is undergoing phase II clinical ...

and more »

Published on Wednesday 10th of March 2010 12:03:28 PM

continue reading